Pharmaceuticals News

Feature article - The great pharma supply chain realignment
Andrew Warmington

Halozyme abandons Evotec bid
Andrew Warmington

Siegfried opens drug substances R&D centre
Andrew Warmington
Three invest further into ADCs
Andrew Warmington

Cambrex exits drug product
Andrew Warmington

Siegfried breaks ground on R&D centre
Andrew Warmington

Drug product centre opens
Andrew Warmington

Evonik realigns Health Care
Andrew Warmington

Quotient integrates drug substance into platform
Andrew Warmington

CordenPharma buys Vifor sites
Andrew Warmington

New owner for Envigo
Andrew Warmington

Quotient to expand Alnwick
Andrew Warmington